Kiplinger’s: Should You Invest Like Buffett?
I am quoted in the May 2018 issue of Kiplinger’s Personal Finance – “What Would Warren Do?”
“Still, at its current price, Teva would not be the bargain for you that it was for Buffett. Teva’s average price was roughly $14.50 a share during the fourth quarter, says David Kass, University of Maryland finance professor and longtime Buffett watcher. If you bought now, you’d pay more than 30% more than Buffett did.”
